A bibliometric research based on hotspots and frontier trends of denosumab

• Main Authors: Bolin Ren (Author), Xiaolei Ren (Author), Lu Wang (Author), Chao Tu (Author), Wenchao Zhang (Author), Zhongyue Liu (Author), Lin Qi (Author), Lu Wan (Author), Ke Pang (Author), Cheng Tao (Author), Zhihong Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Denosumab is a monoclonal antibody that targets and inhibits the osteoclast activating factor receptor activator for nuclear factor-κB ligand (RANKL). It has been widely used in the treatment of osteoporosis, giant cell tumors of bone, and in the prevention of malignant skeletal-related events (SREs...